New platform of preloaded intraocular lenses

New platform of preloaded intraocular lenses
BAUSCH + LOMB has announced the launch of a new platform of preloaded intraocular lenses LUXSMART™ AND LUXGOOD™, which feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. LuxSmart™ and LuxGood™ comprise a hydrophobic material and represent the launch of a new platform for Bausch + Lomb, forming part of a complete range of innovative IOLs. A toric version using the same platform will also become available, in addition to the monofocal and PC-IOLs, according to the company. “With the introduction of LuxSmart™, we are happy to access the presbyopia market with truly innovative premium IOL designs, avoiding the usual dysphotopsic phenomena that can compromise patient vision with typical diffractive optics” said Luc Bonnefoy Vice President Surgical International, Bausch + Lomb. “The Pure Refractive Optics Technology (PRO Technology) represents a great opportunity for patients to experience the benefits of presbyopia-correcting IOLs, but without the discomfort of dysphotopsic symptoms,” said Laura Pérez, Cataract & High-Tech Marketing Manager International, Bausch + Lomb. https://www.bauschsurgical.eu/
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...